Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 Results

▴ Aptus Value Housing Finance India Limited
Going forward, we will continue to prioritize responsible lending and risk management, ensure sustainable growth and asset quality, focus on expanding and retaining customer base both in existing and new geographies and building a strong workforce to further strengthen our position as a leading affordable housing finance company in the country

Chennai: May 03, 2024: Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024.

 

Performance Highlights

 

  • AUM as of FY24 at Rs. 8,722 crores, growth of 29% Y-o-Y
  • Disbursement at Rs. 3,127 crores for FY24, growth of 31% Y-o-Y
  • Distribution network of 262 branches (opened 31 new branches during FY24)
  • PAT at Rs. 612 crores for FY24, growth of 22% Y-o-Y
  • RoA at 8.00%
  • RoE at 17.25%

 

Key Performance Metrics for FY 24                                                                                                                                          (Rs. in Crs)

Particulars

FY 24

FY 23

Y-o-Y

Q4 FY 24

Q4 FY 23

Y-o-Y

Disbursements

  3,127

2,395

31%

         968

         668

45%

AUM

  8,722

6,738

29%

     8,722

     6,738

29%

PAT

      612

503

22%

         164

         135

21%

Spread

8.73%

8.90%

 

8.71%

8.90%

 

Gross NPA (%)

1.07%

1.15%

 

1.07%

1.15%

 

Opex %

2.70%

2.75%

 

2.70%

2.75%

 

RoA (%)

8.00%

8.44%

 

8.00%

8.44%

 

RoE (%)

17.25%

16.34%

 

17.25%

16.34%

 

 

Commenting on the results, Mr. P. Balaji, Managing Director, said,

“I am delighted to announce that FY24 has proven to be a good year for Aptus, marked by significant accomplishments and strong growth. During FY24, we expanded our presence by opening 31 branches, thereby strengthening our network to 262 branches, assuring excellent service to our 1,33,000 +customers. We disbursed 3,127 crores registering a growth of 31% year on year. We sustained consistent growth and achieved an AUM growth of 29% year on year.

The adoption of digital technologies has remained robust, with a consistent enhancement in business generation through leads originating from our customer referral app, eco-partners app, and social media channels. Our customer-centric digital platform, coupled with an AI/ML-driven credit evaluation process, guarantees prompt loan disbursements to our customers. To take the Company to the next level of growth, middle management viz. sales, credit, collections and IT have been strengthened.

Throughout the year, we've consistently maintained low levels of NPAs and remain committed to focus on high quality of assets with Gross NPA at 1.07% as on March 31, 2024.

PAT for FY24 stood at Rs. 612 crores with an increase of 22% y-o-y. Our ROA and ROE remained solid at 8.00% and 17.25% respectively.

As on March 31, 2024, we have maintained a sufficient liquidity of Rs. 1022 crores including undrawn sanctions of Rs. 620 crores from various banks. The Company is well capitalized with a net worth of over Rs. 3,700 crores.

Going forward, we will continue to prioritize responsible lending and risk management, ensure sustainable growth and asset quality, focus on expanding and retaining customer base both in existing and new geographies and building a strong workforce to further strengthen our position as a leading affordable housing finance company in the country.”

 

About Aptus Value Housing Finance India Limited: (aptusindia.com; BSE: 543335; NSE: APTUS)

Aptus Value Housing Finance India Limited is amongst the fastest growing & profitable affordable housing finance Company with a network of 262 branches catering to over 1,33,000 active live accounts in Tamil Nadu, Union Territory of Puducherry, Telangana, Andhra Pradesh, Karnataka, Odisha and Maharashtra. The company offers home loans for purchase and self-construction of residential property, home improvement, extension loans, loan against property and business loans to the low and middle-income groups.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026